Implementation of patient reported outcomes in definitive chemoradiation for non-small cell lung cancer
We appreciate the critical review of our analysis of patient reported outcome measures (PROMs) in definitive chemoradiation for non-small cell lung cancer (NSCLC). In their editorial, Voong et al. thoughtfully discuss use of PROMs in locally advanced lung cancer. They highlight important limitations of our data, many of which are commonly encountered in studies of patient reported outcomes (PROs).